心不全POCとLOCデバイス市場分析レポート：タイプ別、技術別、最終用途別、地域別、およびセグメント予測、2025～2030年

心不全POCとLOCデバイス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の心不全POCとLOCデバイス市場規模は2030年までに2億5,102万米ドルに達すると予測され、2025～2030年にかけて15.09％のCAGRで成長すると予測されています。

診断セグメントでは、医療コストの上昇を抑制するための実行可能な戦略として、疾患の後期発見から早期発見へのパラダイムシフトが市場を牽引しています。このシフトは、心臓発作を起こすリスクを評価するために1つの検体から心臓バイオマーカーを検出するために、様々なセンサと関連アクセサリを1つの空間に統合した使い捨てで低コストのLOCデバイスの開発につながりました。

さらに、LOCアッセイによって測定されたデータを分析して治療モニタリングを可能にする予測モデリング技術ベースの意思決定支援ソフトウェアの開発は、市場促進要因の1つです。また、心筋梗塞を測定するための唾液ベースのナノ・バイオチップ検査の応用に関する進行中の研究が、有機的な収益成長の原動力となっています。

POC検査は、病院、一般クリニック、遠隔地など、さまざまな環境において節約の可能性を示しています。米国では、POC機器の採用により胸痛治療室への入院が20％減少し、時間とコストの大幅な節約につながりました。

心臓観察室（米国）では、POCトロポニン検査の導入により、在院日数が短縮され、入院率が低下し、費用のかかる複数の処置の必要性がなくなり、患者1人当たり25％のコスト削減が実現しました。さらに、個人の心臓の健康を管理するためのPOC診断におけるスマートフォンとアプリの統合は、心不全POCとLOCデバイス市場における重要な技術革新の1つです。

心不全POCとLOCデバイス市場レポートハイライト

• プロテオミクス分析には、トロポニン、ミオグロビン、クレアチンキナーゼMBアイソザイム（CK-MB）などのタンパク質マーカーを検査する製品が含まれます。
• 現在入手可能な製品のほとんどがタンパク質マーカーの検査に基づいているため、このセグメントは主要な収益シェアを占めています。
• 推定バイオマーカーを評価するためのマイクロ流体LOC技術の導入が増加していることが、この技術の最大の収益シェアにつながっています。
• マイクロ流体技術は、免疫ハイブリダイゼーション技術、酵素アッセイ、PCRなど、さまざまな生物学的アプリケーションに導入されています。
• 医院、薬局・小売クリニック、急患クリニック、非クリニックを含むクリニックは、主要な収益を生み出すエンドユーザーです。
• 一般開業医が迅速な調査、早期治療の決定、タイムリーな発表、患者の不確実性の軽減のためにPOC機器を使用する割合が高いことが、クリニックを通じた収益成長の原動力となっています。
• 米国は、心不全の早期発見の手段としてPOC心臓マーカー検査を導入しているプライマリケアクリニックの数が多いため、世界の心不全POC＆LOCデバイス市場を独占しています。
• 都市化の拡大と高齢者の増加が、アジア諸国における日常的な心臓健康モニタリングのためのPOC診断のような強固で改善された医療サービスへの需要を下支えしています。
• さらに、POC心筋トロポニンT/心筋トロポニンIバイオマーカーに関する若い医療担当者のトレーニングの取り組みも行われています。この結果、アジア諸国ではPOC機器の採用率が急上昇すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場セグメンテーションと範囲
• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場動向と展望
• 市場力学
• 市場抑制要因分析
• ビジネス環境分析
  • SWOT分析、要因別（政治・法律、経済技術）
  • ポーターのファイブフォース分析

第4章 タイプビジネス分析

• 心不全POCとLOCデバイス市場：タイプ変動分析
• プロテオーム検査
  • プロテオーム検査市場、2018～2030年
• メタボロミクス検査
  • メタボロミクス検査市場、2018～2030年
• ゲノム検査
  • ゲノム検査市場、2018～2030年

第5章 技術ビジネス分析

• 心不全POCとLOCデバイス市場：技術変動分析
• マイクロ流体
  • マイクロ流体市場、2018～2030年
• アレイベースシステム
  • アレイベースシステム市場、2018～2030年
• その他
  • その他市場、2018～2030年

第6章 最終用途ビジネス分析

• 心不全POCとLOCデバイス市場：最終用途の変動分析
• 病院
  • 病院市場、2018～2030年
• ラボ
  • ラボ市場、2018～2030年
• クリニック
  • クリニック市場、2018～2030年
• 住宅
  • 住宅市場、2018～2030年
• 介護付き生活医療施設
  • 介護付き生活医療施設市場、2018～2030年

第7章 地域ビジネス分析

• 心不全POCとLOCデバイスの市場シェア（地域別）、2024年と2030年
• 北米
  • 北米の心不全POCとLOCデバイス市場、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の心不全POCとLOCデバイス市場、2018～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋の心不全POCとLOCデバイス市場、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカの心不全POCとLOCデバイス市場、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカの心不全POCとLOCデバイス市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市場シェア分析、2024年
• 企業プロファイル/上場企業
  • Abbott
  • Danahar
  • Siemens Healthineers
  • F. Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • bioMerieux SA
  • Trinity BIoTech
  • Abaxis, Inc

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 4 Global Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 5 Global Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 6 Global Heart Failure POC & LOC Devices Market, by Region, 2018 - 2030 (USD Million)
• Table 7 North America Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
• Table 8 North America Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 9 North America Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 10 North America Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 11 U.S. Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 12 U.S. Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 13 U.S. Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 14 Mexico Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 15 Mexico Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 16 Mexico Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 17 Canada Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 18 Canada Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 19 Canada Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 20 Europe Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
• Table 21 Europe Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 22 Europe Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 23 Europe Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 24 Germany Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 25 Germany Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 26 Germany Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 27 UK Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 28 UK Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 29 UK Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 30 France Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 31 France Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 32 France Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 33 Italy Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 34 Italy Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 35 Italy Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 36 Spain Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 37 Spain Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 38 Spain Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 39 Denmark Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 40 Denmark Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 41 Denmark Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 42 Sweden Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 43 Sweden Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 44 Sweden Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 45 Norway Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 46 Norway Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 47 Norway Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 52 China Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 53 China Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 54 China Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 55 Japan Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 56 Japan Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 57 Japan Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 58 India Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 59 India Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 60 India Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 61 South Korea Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 62 South Korea Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 63 South Korea Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 64 Australia Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 65 Australia Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 66 Australia Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 67 Thailand Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 68 Thailand Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 69 Thailand Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 70 Latin America Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
• Table 71 Latin America Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 72 Latin America Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 73 Latin America Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 74 Brazil Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 75 Brazil Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 76 Brazil Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 77 Argentina Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 78 Argentina Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 79 Argentina Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 84 South Africa Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 85 South Africa Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 86 South Africa Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 90 UAE Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 91 UAE Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 92 UAE Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
• Table 93 Kuwait Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
• Table 94 Kuwait Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
• Table 95 Kuwait Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Heart Failure POC & LOC Devices Market Segmentation
• Fig. 8 Market Snapshot, 2024
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Global Heart Failure POC & LOC Devices Market, Type Movement Analysis
• Fig. 16 Global Heart Failure POC & LOC Devices Market, for Proteomic Testing, 2018 - 2030 (USD Million)
• Fig. 17 Global Heart Failure POC & LOC Devices Market, for Metabolomic Testing, 2018 - 2030 (USD Million)
• Fig. 18 Global Heart Failure POC & LOC Devices Market, for Genomic Testing, 2018 - 2030 (USD Million)
• Fig. 19 Global Heart Failure POC & LOC Devices Market, Technology Movement Analysis
• Fig. 20 Global Heart Failure POC & LOC Devices Market, for Microfluidics, 2018 - 2030 (USD Million)
• Fig. 21 Global Heart Failure POC & LOC Devices Market, for Array-based Systems, 2018 - 2030 (USD Million)
• Fig. 22 Global Heart Failure POC & LOC Devices Market, for Others, 2018 - 2030 (USD Million)
• Fig. 23 Global Heart Failure POC & LOC Devices Market, End-use Movement Analysis
• Fig. 24 Global Heart Failure POC & LOC Devices Market, for Hospitals, 2018 - 2030 (USD Million)
• Fig. 25 Global Heart Failure POC & LOC Devices Market, for Laboratories, 2018 - 2030 (USD Million)
• Fig. 26 Global Heart Failure POC & LOC Devices Market, for Clinics, 2018 - 2030 (USD Million)
• Fig. 27 Global Heart Failure POC & LOC Devices Market, for Home, 2018 - 2030 (USD Million)
• Fig. 28 Global Heart Failure POC & LOC Devices Market, for Assisted Living Healthcare Facilities, 2018 - 2030 (USD Million)
• Fig. 29 Regional Marketplace: Key Takeaways
• Fig. 30 Regional Outlook, 2024 & 2030
• Fig. 31 Global Heart Failure POC & LOC Devices Market, Region Movement Analysis
• Fig. 32 North America Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 33 U.S. Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 34 Canada Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 35 Mexico Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 36 Europe Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 37 Germany Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 38 UK Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 39 France Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 40 Italy Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 41 Spain Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 42 Denmark Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 43 Sweden Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 44 Norway Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 45 Asia Pacific Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 46 Japan Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 47 China Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 48 India Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 49 Australia Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 50 South Korea Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 51 Thailand Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 52 Latin America Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 53 Brazil Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 54 Argentina Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 55 Middle East and Africa Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 56 South Africa Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 57 Saudi Arabia Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 58 UAE Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
• Fig. 59 Kuwait Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)

Heart Failure POC And LOC Devices Market Growth & Trends:

The global heart failure POC and LOC devices market size is expected to reach USD 251.02 million by 2030 and is projected to grow at a CAGR of 15.09% from 2025 to 2030, according to a new report by Grand View Research, Inc. A paradigm shift in diagnostic sectors from late-stage disease detection to early identification of diseases as a viable strategy to curb rising healthcare costs has driven the market. This shift has led to the development of disposable and low-cost LOC devices that integrate various sensors and associated accessories in a single space for detection of the cardiac biomarkers from a single specimen to evaluate the risk of having a heart attack.

Furthermore, the development of predictive modeling techniques-based decision support software to analyze the data measured by the LOC assays to enable therapy monitoring is one of the key market drivers. Also, ongoing studies on the application of saliva-based nano-biochip tests for measuring myocardial infarction is driving organic revenue growth.

POC testing exhibits potential savings across various settings, including hospitals, general practice, and remote areas. In the U.S., the employment of POC devices resulted in a 20% decrease in hospital admissions to the chest pain unit, resulting in substantial savings in time and costs.

In the cardiac observation unit (U.S.), the implementation of POC troponin testing helped reduce hospital stays, decrease admission rates, and remove the need for multiple costly procedures, resulting in 25% cost saving per patient. Furthermore, the integration of smartphones and apps in POC diagnostics for managing the cardiac health of an individual is one of the significant innovations in Heart Failure POC & LOC Devices market.

Heart Failure POC And LOC Devices Market Report Highlights:

• Proteomic analysis includes products that test protein markers, such as troponin, myoglobin, and Creatine Kinase MB Isoenzyme (CK-MB)
• This segment accounted for the leading revenue share, as most of the currently available products are based on testing of protein markers
• Increasing implementation of microfluidic LOC technology for assessing putative biomarkers has led to the largest revenue share of this technology
• Microfluidic technology has been implemented for various biological applications, such as immunohybridization techniques, enzymatic assays, PCR, and others
• Clinics that include physician's office, pharmacy & retail clinics, urgent care clinics, and non-practice clinics are the key revenue generating end-users
• A high usage rate of POC devices by general practitioners for rapid investigation, deciding early treatment, timely referral, and less uncertainty for patients has driven the revenue growth through clinics
• The U.S. dominated the global Heart Failure POC & LOC devices market owing to the presence of a substantial number of primary care clinics that are deploying POC cardiac marker test as a measure for early detection of heart failure
• Expanding urbanization and increasing geriatric population underpin the demand for robust and improved healthcare services such as POC diagnostics for routine cardiac health monitoring in Asian countries
• Moreover, initiatives are undertaken for training young healthcare personnel about POC cardiac troponin T/cardiac troponin I biomarkers. This, in turn, is anticipated to result in the surging adoption rate of POC devices in Asian countries

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model
  • 1.4.1. Market Study, By Company Market Share
  • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
• 3.5. Market Restraint Analysis
• 3.6. Business Environment Analysis
  • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

• 4.1. Heart Failure POC & LOC Devices Market: Type Movement Analysis
• 4.2. Proteomic Testing
  • 4.2.1. Proteomic Testing Market, 2018 - 2030 (USD Million)
• 4.3. Metabolomic Testing
  • 4.3.1. Metabolomic Testing Market, 2018 - 2030 (USD Million)
• 4.4. Genomic Testing
  • 4.4.1. Genomic Testing Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

• 5.1. Heart Failure POC & LOC Devices Market: Technology Movement Analysis
• 5.2. Microfluidics
  • 5.2.1. Microfluidics Market, 2018 - 2030 (USD Million)
• 5.3. Array-based Systems
  • 5.3.1. Array-based Systems Market, 2018 - 2030 (USD Million)
• 5.4. Others
  • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

• 6.1. Heart Failure POC & LOC Devices Market: End-use Movement Analysis
• 6.2. Hospitals
  • 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
• 6.3. Laboratories
  • 6.3.1. Laboratories Market, 2018 - 2030 (USD Million)
• 6.4. Clinics
  • 6.4.1. Clinics Market, 2018 - 2030 (USD Million)
• 6.5. Home
  • 6.5.1. Home Market, 2018 - 2030 (USD Million)
• 6.6. Assisted Living Healthcare Facilities
  • 6.6.1. Assisted Living Healthcare Facilities Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Heart Failure POC & LOC Devices Market Share By Region, 2024 & 2030
• 7.2. North America
  • 7.2.1. North America Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Target Disease Prevalence
    • 7.2.2.3. Competitive Scenario
    • 7.2.2.4. Regulatory Framework
    • 7.2.2.5. Reimbursement Scenario
    • 7.2.2.6. U.S. Heart failure POC & LOC devices Market, 2018 - 2030 (USD MILLION)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Target Disease Prevalence
    • 7.2.3.3. Competitive Scenario
    • 7.2.3.4. Regulatory Framework
    • 7.2.3.5. Reimbursement Scenario
    • 7.2.3.6. Canada Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Target Disease Prevalence
    • 7.2.4.3. Competitive Scenario
    • 7.2.4.4. Regulatory Framework
    • 7.2.4.5. Reimbursement Scenario
    • 7.2.4.6. Mexico Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3.2. Germany
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Target Disease Prevalence
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
    • 7.3.2.5. Reimbursement Scenario
    • 7.3.2.6. Germany Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3.3. UK
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
    • 7.3.3.5. Reimbursement Scenario
    • 7.3.3.6. UK Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Target Disease Prevalence
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. Regulatory Framework
    • 7.3.4.5. Reimbursement Scenario
    • 7.3.4.6. France Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Target Disease Prevalence
    • 7.3.5.3. Competitive Scenario
    • 7.3.5.4. Regulatory Framework
    • 7.3.5.5. Reimbursement Scenario
    • 7.3.5.6. Italy Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Target Disease Prevalence
    • 7.3.6.3. Competitive Scenario
    • 7.3.6.4. Regulatory Framework
    • 7.3.6.5. Reimbursement Scenario
    • 7.3.6.6. Spain Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Target Disease Prevalence
    • 7.3.7.3. Competitive Scenario
    • 7.3.7.4. Regulatory Framework
    • 7.3.7.5. Reimbursement Scenario
    • 7.3.7.6. Denmark Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Target Disease Prevalence
    • 7.3.8.3. Competitive Scenario
    • 7.3.8.4. Regulatory Framework
    • 7.3.8.5. Reimbursement Scenario
    • 7.3.8.6. Sweden Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Target Disease Prevalence
    • 7.3.9.3. Competitive Scenario
    • 7.3.9.4. Regulatory Framework
    • 7.3.9.5. Reimbursement Scenario
    • 7.3.9.6. Norway Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
    • 7.4.2.5. Reimbursement Scenario
    • 7.4.2.6. Japan Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
    • 7.4.3.5. Reimbursement Scenario
    • 7.4.3.6. China Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
    • 7.4.4.5. Reimbursement Scenario
    • 7.4.4.6. India Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
    • 7.4.5.5. Reimbursement Scenario
    • 7.4.5.6. South Korea Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Reimbursement Scenario
    • 7.4.6.6. Australia Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
    • 7.4.7.5. Reimbursement Scenario
    • 7.4.7.6. Thailand Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
    • 7.5.2.5. Reimbursement Scenario
    • 7.5.2.6. Brazil Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
    • 7.5.3.5. Reimbursement Scenario
    • 7.5.3.6. Argentina Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
    • 7.6.2.5. Reimbursement Scenario
    • 7.6.2.6. South Africa Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
    • 7.6.3.5. Reimbursement Scenario
    • 7.6.3.6. Saudi Arabia Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Target Disease Prevalence
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Regulatory Framework
    • 7.6.4.5. Reimbursement Scenario
    • 7.6.4.6. UAE Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Target Disease Prevalence
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Regulatory Framework
    • 7.6.5.5. Reimbursement Scenario
    • 7.6.5.6. Kuwait Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Share Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Abbott
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.1.3. Collection Site Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Danahar
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.2.3. Collection Site Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Siemens Healthineers
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.3.3. Collection Site Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. F. Hoffmann-La Roche Ltd.
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.4.3. Collection Site Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Quidel Corporation
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.5.3. Collection Site Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. bioMerieux S.A
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.6.3. Collection Site Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Trinity Biotech
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.7.3. Collection Site Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Abaxis, Inc
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.8.3. Collection Site Benchmarking
    • 8.4.8.4. Strategic Initiatives